Clinical Trials Directory

Trials / Sponsors / ZevraDenmark

ZevraDenmark

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
TerminatedArimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial
Amyotrophic Lateral Sclerosis
Phase 32019-09-19
TerminatedArimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial
Inclusion Body Myositis
Phase 32019-05-20
CompletedArimoclomol in Amyotropic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
Phase 32018-07-31
TerminatedStudy of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3
Gaucher Disease, Type 1, Gaucher Disease, Type 3
Phase 22018-06-06
CompletedStudy of Arimoclomol in Inclusion Body Myositis (IBM)
Inclusion Body Myositis
Phase 22017-08-16
CompletedArimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C
Niemann-Pick Disease, Type C
Phase 2 / Phase 32016-06-14
CompletedA Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C
Niemann-Pick Disease, Type C
—2015-09-01
AvailableEarly Access Program With Arimoclomol in US Patients With NPC
Niemann-Pick Disease, Type C
——